RUTH WIELAND: Open Payments
NPI 1184622607 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,156 in 72 payments from 21 companies in 2025. Trend: 2023 $1,289 · 2024 $1,618 · 2025 $1,156
Food & beverage: $1,156
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $209 |
| ABBVIE INC. | 19 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $106 |
| PFIZER INC. | 5 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| ACADIA Pharmaceuticals Inc | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $67 |
| Abbott Laboratories | 3 | $61 |
| Dexcom, Inc. | 2 | $42 |
| Recor Medical Inc | 1 | $34 |
Products named: XIFAXAN, Wegovy, UBRELVY, Ozempic, NUPLAZID, LEQVIO, FREESTYLE LIBRE 3, VRAYLAR.
Industry payments across SC — which companies pay providers there.
